Abstract
Objective
To evaluate the risk of high-risk human papillomavirus (HPV) infection in women with Trichomonas vaginalis infection, and the reason remains unclear.
Methods
A total of 40,000 liquid-based cytology specimens were tested from 2005 to 2008. Among these, high-risk HPV testing using the hybrid capture II assay was performed in positive cases of T. vaginalis according to the age of patients (<30 years old, between 30 and 50 years old, more than 50 years old). As controls, HPV detection was also performed in 450 normal smears.
Results
T. vaginalis was found in 80 cases (0.2%). From these 80 cases, 57 were available for HPV testing (8 patients <30 years old, 42 patients between 30 and 50 years old and 7 patients more than 50 years old). As controls, high-risk HPV was tested in 150 patients with normal cytology for each of these three age categories. High-risk HPV was significantly more frequently detected in women with T. vaginalis than in women with normal smear irrespective of the categories of age (P < 0.01).
Conclusion
For the first time, we demonstrated a significant prevalence of high-risk HPV in women with cytological proved T. vaginalis infection independent of the age ranges. Our data suggest a potential association between these two infectious agents by the way of a sexual intercourse and probably by a biochemical or immunological reasons.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
World Health Organization (2001) Global prevalence and incidence of selected curable sexually transmitted infections: overview and estimates. In: WHO, Geneva, pp 27–29
Marrone J, Fairley CK, Saville M et al (2008) Temporal associations with declining Trichomonas vaginalis diagnosis rates among women in the state of Victoria, Australia, 1947–2005. Sex Transm Dis 35:572–576
Workowski KA, Berman SM (2006) Centers for disease control and prevention. Sexually transmitted diseases treatment guidelines. MMWR Morb Mortal Wkly Rep 55(RR-11):52–54
Sutton M, Sternberg M, Koumans EH et al (2007) The prevalence of trichomonas vaginalis infection among reproductive-age women in the united states, 2001–2004. Clin Infect Dis 45:1319–1326
Laga M, Manoka A, Kivuvu M et al (1993) Non ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 7:95–102
Miller M, Liao Y, Gomez AM, Gaydos CA, D’Mellow D (2008) Factors associated with the prevalence and incidence of Trichomonas vaginalis infection among African American women in New York City who use drugs. J Infect Dis 197:503–509
Schwebke JR (2002) Update of trichomoniasis. Sex Transm Infect 78:378–479
Van Der Pol B, Williams JA, Orr DP, Batteiger BE, Fortenberry JD (2005) Prevalence, incidence, natural history, and response to treatment of trichomonas vaginalis infection among adolescent women. J Infect Dis 192:2039–2044
El-Gayar EK, Rashwan MF (2007) Cervical intraepithelial neoplasia (CIN) and Trichomonas vaginalis infection as revealed by polymerase chain reaction. J Egypt Soc Parasitol 37:623–630
Gram IT, Macaluso M, Churchill J, Stalsberg H (1992) Trichomonas vaginalis (TV) and human papillomavirus (HPV) infection and the incidence of cervical intraepithelial neoplasia (CIN) grade III. Cancer Causes Control 3(3):321–326
Kharsany ABM, Hoosen AA, Moodley J, Bagaratee J, Gouws E (1993) The association between sexually transmitted pathogens and cervical intra-epithelial neoplasia in a developing community. Genitourin Med 69:357–360
Verteramo R, Pierangeli A, Mancini E et al (2009) Human papillomaviruses and genital co-infections in gynaecological outpatients. BMC Infect Dis. doi:10.1186/1471-2334-9-16
Zhang ZF, Begg CB (1994) Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies. Int J Epidmiol 23:682–690
Gray W, McKee GT (2002) Female genital tract. Normal vulva, vagina and cervix: hormonal and inflammatory conditions. In: Livingstone Churchill (ed) Diagnostic cytopathology, 2nd edn. Livingstone Churchill, Philadelphia, pp 682–684
Noel JC, Bucella D, Fayt I, Romero-Munoz MR, Simon P (2006) HPV et dépistage du cancer du col utérin. Ann Pathol 26:389–396
Lossick JG (1989) Epidemiology of urogenital trichomoniasis. In: Honigberg BM (ed) Trichomonads parasitic in humans. Springer, New York, pp 311–323
Storti-Filho A, Souza PC, Chassot F (2009)Association of public versus private health care utilization and prevalence of Trichomonas vaginalis in Maringa, Parana, Brazil. Arch Gynecol Obstet. doi:10.1007/s00404-009-0971-x
Rughooputh S, Greenwell P (2005) Trichomonas vaginalis: paradigm of a successful sexually transmitted organism. Br J Biomed Sci 62:193–200
Provenzano D, Khoshnan A, Alderete JF (1997) Involvement of dsRNA virus in the protein composition and growth kinetics of host Trichomonas vaginalis. Arch Virol 142:939–952
Arroyo R, Aldetere JF (1995) Two Trichomonas vaginalis surface proteinases bind to host epithelial cells and are related to levels of cytoadherence and cytotoxicity. Arch Med Res 26:279–285
Wang A, Wang CC, Aldetere JF (1987) Trichomonas vaginalis phenotypic variation occurs only among trichomonads infected with the double-stranded RNA virus. J Exp Med 166:142–150
Scheurer ME, Tortolero-Luna G, Adler-Storthz K (2005) Human papillomavirus infection: biology, epidemiology, and prevention. Int J Gynecol Cancer 15:727–745
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Noël, JC., Fayt, I., Romero Munoz, M.R. et al. High prevalence of high-risk human papillomavirus infection among women with Trichomonas vaginalis infection on monolayer cytology. Arch Gynecol Obstet 282, 503–505 (2010). https://doi.org/10.1007/s00404-009-1291-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-009-1291-x